Sector Chart Guardant Health, Inc.

Equities

GH

US40131M1099

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
104.85 ^USD	+2.03%		-0.47%	+2.65%

02-02	Guardant Health, Inc. Announces Publication of the Largest Study to Date Evaluating Circulating Tumors forMRD Detection in Patients with Rescted Stage III Colon Cancer After Surgery and Before Adjuvant Chemotherapy	CI
01-30	UBS Adjusts Price Target on Guardant Health to $175 From $110, Maintains Buy Rating	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Diagnostic & Testing Substances

	Capi.	Sales growth	Profitability	Finances	EV / Sales	P/E
GUARDANT HEALTH, INC.	13.51B					-
BIOMÉRIEUX	13B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	5.92B
CARIS LIFE SCIENCES, INC.	5.82B	-	-	-	-	-
DIASORIN S.P.A.	4.73B
LANTHEUS HOLDINGS, INC.	4.6B